Recent Insider Transactions - Cue Biopharma (NASDAQ: CUE)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ CUE Cue Biopharma

Millar Kerri-Ann / officer: CHIEF FINANCIAL OFFICER

03/21/2025

Buy

$0.99

200,000

$198K

200,000

NASDAQ CUE Cue Biopharma

PASSERI DANIEL R / director, officer: CHIEF EXECUTIVE OFFICER

03/21/2025

Buy

$0.99

450,000

$446K

450,000

NASDAQ CUE Cue Biopharma

Baker Daniel G. / officer: CHIEF DEVELOPMENT OFFICER

03/21/2025

Buy

$0.99

100,000

$99K

100,000

NASDAQ CUE Cue Biopharma

Sandercock Colin / officer: SVP, GENERAL COUNSEL

03/21/2025

Buy

$0.99

200,000

$198K

200,000

NASDAQ CUE Cue Biopharma

Warren Lucinda / officer: CHIEF BUSINESS OFFICER

03/21/2025

Buy

$0.99

250,000

$248K

250,000

NASDAQ CUE Cue Biopharma

Levisetti Matteo / officer: Chief Medical Officer

03/21/2025

Buy

$0.99

250,000

$248K

250,000

NASDAQ CUE Cue Biopharma

Sarraf Pasha / director

03/10/2025

Buy

$1.03

48,800

$50K

48,800